Cam­bri­an's an­ti-ag­ing mis­sion ex­pands with new fi­brot­ic dis­ease biotech

3 years ago
Startups

Scoop: Biotech de­vel­op­ing oral Alzheimer's drug is on $50M hunt

3 years ago
Financing
Startups

Google health tech spin­out Ver­i­ly lays off staff amid ex­ec de­par­tures

3 years ago
People

Leg­is­la­tors call HHS to ac­tion on Xtan­di march-in rights

3 years ago
Pharma

Con­tract man­u­fac­tur­er nets cap­i­tal in­vest­ment to ex­pand its phys­i­cal space and in­stall a new fill-fin­ish line

3 years ago
Manufacturing

Ex­perts talk IRA im­pacts as CMS an­nounces it will pub­lish first 10 drugs up for ne­go­ti­a­tion in Sep­tem­ber

3 years ago
R&D
Pharma

Cannes Li­ons names ju­ry chiefs for 2023 ad cre­ativ­i­ty show, Om­ni­com and VM­LY&R ex­ecs helm health pan­els

3 years ago
Pharma
Marketing

Sun Phar­ma fa­cil­i­ty un­der an im­port alert hand­ed a warn­ing let­ter

3 years ago
Pharma
FDA+

Mer­ck leads bio­phar­mas in an­nu­al ‘just’ busi­ness rank­ing, while GSK and Sanofi nab sus­tain­abil­i­ty hon­ors

3 years ago
Pharma
Marketing

ICY­MI: 'What could they pos­si­bly buy?' Sanofi's Paul Hud­son talks M&A hes­i­ta­tion at #JPM23

3 years ago
Deals
Pharma

Q&A: How to at­tract the eye of an ear­ly in­vestor in biotech R&D tools

3 years ago
Financing

Ei­sai chief Ivan Che­ung 'not wor­ried at al­l' about Leqem­bi's full ap­proval

3 years ago
Pharma

Sanofi ex­tends com­mit­ment to $750M biotech start­up fund

3 years ago
Financing
Startups

As Il­lu­mi­na dis­ap­points Wall Street, com­peti­tors make their case at JPM

3 years ago
R&D

Flame Bio­sciences search­es for fu­ture af­ter No­var­tis flunks on canakinum­ab

3 years ago
Startups
R&D

Ver­tex gets more pre­cise with Ar­bor in ex­pand­ed gene edit­ing pact

3 years ago
Startups
Deals

As­traZeneca and Avil­lion win ap­proval for new asth­ma res­cue treat­ment in adults

3 years ago
Pharma
FDA+

Da­ta to dol­lars: Geron sells stock to raise over $200M af­ter PhI­II read­out on MDS drug

3 years ago
Financing

Up­dat­ed: Roche, Io­n­is launch new Hunt­ing­ton’s dis­ease study

3 years ago
R&D

Spec­trum Labs is­sues world­wide re­call of ep­i­neph­rine in­gre­di­ent

3 years ago
Pharma
Manufacturing

Supreme Court re­jects Pfiz­er's bid to re­view an­ti-kick­back case

3 years ago
Pharma
Law

Co­herus pays out $32M for ex­clu­sive US com­mer­cial­iza­tion rights to Eylea biosim­i­lar

3 years ago
Deals

Next-gen Covid vac­cines: No more quick vari­ant up­dates and RCTs may be re­quired, CBER leader writes

3 years ago
FDA+
Coronavirus

Re­silience starts the year with its first deal out­side of North Amer­i­ca

3 years ago
Deals
Manufacturing
First page Previous page 403404405406407408409 Next page Last page
A service from the Financial Times